Storia in 4 fonti

Weekly diabetes jab shown to reduce blood-sugar levels and body weight

Experts say results from trial of new triple hormone drug for type 2 diabetes are striking but further tests needed

Raccontata da

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

theguardian.comStai leggendo1 mese fa

Weekly diabetes jab shown to reduce blood-sugar levels and body weight

Retatrutide, Eli Lilly's weekly injection, reduced HbA1c 1.7-1.9 points and weight 11.5-15.3% in 930 diabetics—4× better than placebo. For health IT leaders, this signals a market shift toward multi-target biologics, reshaping pharma partnerships and healthcare data infrastructure investments.

originale

Timeline cronologica

domenica 7 giugno 2026·theguardian.com
Weekly diabetes jab shown to reduce blood-sugar levels and body weight
Experts say results from trial of new triple hormone drug for type 2 diabetes are striking but further tests needed
domenica 7 giugno 2026·gulfnews.com
New weekly diabetes jab cuts blood sugar, body weight in major trial
New weekly diabetes jab retatrutide cuts blood sugar and drives double-digit weight loss in type 2 diabetes patients in major phase 3 trial, The Lancet reports.

Weekly diabetes jab shown to reduce blood-sugar levels and body weight

Confronto fonti

Weekly diabetes jab shown to reduce blood-sugar levels and body weight

Timeline cronologica

Weekly diabetes jab shown to reduce blood-sugar levels and body weight

New weekly diabetes jab cuts blood sugar, body weight in major trial

This triple-action jab can lower your blood sugar and weight

New weekly diabetes jab cuts blood sugar, body weight in major trial

Up to 40% of Diabetes Patients Achieved Normal HbA1c With Retatrutide

Up to 40% of Diabetes Patients Achieved Normal HbA1c With Retatrutide

This triple-action jab can lower your blood sugar and weight